Pro-Dex, Inc.
PDEXPro-Dex, Inc. in brief
Pro-Dex, Inc. is a listed company in the Medical Instruments industry, based in Irvine, California, USA. Its market value was $199 M on 28 October 2026, which makes it the 16,259th largest listed company in the world and the 3,154th largest in the USA on this site. In the year to June 2026 it had sales of $78 M and a net profit of $14 M, about 18 cents of profit for every dollar of sales. It employs about 206 people and Richard Lee Van Kirk Jr. is its chief executive. Its shares trade under the symbol PDEX (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Pro-Dex, Inc.
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions that appeal to our customers, primarily medical device distributors. Additionally, we provide engineering, quality and regulatory consulting services to our customers. We also manufacture and sell rotary air motors to a wide range of industries; however, these motors comprise a de minimis portion of our business. Beginning in fiscal 2026, we began selling precision machined parts and assemblies for the aerospace and defense industries through our newly acquired subsidiary, Advanced Precision Machining, LLC.
From the company's annual report filed with the US SEC: read the report
Pro-Dex, Inc. timeline
- 1995
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2026
- 💰Record revenue of $78 millionFY2026, the highest of the 9 years on record.
- 💰Record net income of $14 millionFY2026, the highest profit of the 9 years on record.
Events of Pro-Dex, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,915 (Jan 2020) · #3,574 (Jan 2021) · #4,501 (Jan 2022) · #4,669 (Dec 2022) · #4,554 (Jul 2023) · #3,928 (Jan 2024) · #1,821 (Mar 2026) · #3,070 (Aug 2026) · #3,138 (Oct 2026) · #3,158 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 16.6×
- Price / sales (TTM)
- 2.5×
- Price / book
- 4.2×
- Free cash flow yield
- 3.4%
- Net margin (TTM)
- 15.1%
- Operating margin
- 16.8%
- Return on equity
- 25.3%
- Liabilities / assets
- 36.1%
- Net debt
- $9M
- Revenue growth
- +16.5%
- R&D / revenue
- 4.3%
- Revenue per employee
- $376 K
- Profit per employee
- $66 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $78M | +16.5% | $13M | $14M | 17.6% |
| Jun 2025 | $67M | +23.7% | $11M | $9M | 13.5% |
| Jun 2024 | $54M | +16.8% | $7M | $2M | 4.0% |
| Jun 2023 | $46M | +9.6% | $6M | $7M | 15.3% |
| Jun 2022 | $42M | +10.5% | $5M | $5M | 10.9% |
| Jun 2021 | $38M | +9.2% | $5M | $6M | 16.2% |
| Jun 2020 | $35M | +28.2% | $7M | $6M | 17.5% |
| Jun 2019 | $27M | — | $5M | $4M | 15.3% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Jun 2026 | $7M | $0M | $7M | $4.12 | — |
| Jun 2025 | $-2M | $1M | $-3M | $2.67 | — |
| Jun 2024 | $6M | — | — | $0.60 | — |
| Jun 2023 | $5M | — | — | $1.95 | — |
| Jun 2022 | $-1M | $2M | $-2M | $1.21 | — |
| Jun 2021 | $-2M | $2M | $-4M | $1.57 | — |
| Jun 2020 | $5M | $1M | $4M | $1.50 | — |
| Jun 2019 | $3M | $1M | $2M | $0.97 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $21M (+11.0% on a year earlier), net income $3M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Oct 30, 20268-KCurrent reportMaterial agreement
- Oct 29, 20268-KCurrent reportResults of operations
- Oct 29, 202610-QQuarterly report · period to Sep 2026
- Oct 6, 2026DEF 14AProxy statement
- Sep 18, 20268-KCurrent reportMaterial agreement
- Sep 3, 20268-KCurrent reportResults of operations
- Sep 3, 202610-KAnnual report · period to Jun 2026
- Aug 28, 20268-KCurrent reportDirectors or officers changed
- Jun 17, 20268-KCurrent reportRegulation FD disclosure
- Apr 30, 20268-KCurrent reportResults of operations
- Apr 30, 202610-QQuarterly report · period to Mar 2026
- Mar 27, 20268-KCurrent reportDirectors or officers changed
Official filings of Pro-Dex, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $78 M
- Operating income
- $13 M
- Net income
- $14 M
For year ending June-2026 · source: SEC filing
Balance sheet
- Total assets
- $75 M
- Total liabilities
- $27 M
- Total equity
- $48 M
As of June-2026
Top 85 institutional investors in Pro-Dex, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 156,094 | +2,916 (+1.90%) | 4.88% | $11 M | Nov 13, 2026 |
| 2 | Global Retirement Partners, LLC | 78,901 | +77,901 (+7790.10%) | 2.47% | $5 M | Nov 10, 2026 |
| 3 | Vanguard Capital Management LLC | 77,491 | -4,792 (-5.82%) | 2.42% | $5 M | Nov 13, 2026 |
| 4 | Dimensional Fund Advisors LP | 62,633 | +5,572 (+9.76%) | 1.96% | $4 M | Nov 4, 2026 |
| 5 | Punch & Associates Investment Management, Inc. | 50,437 | -2,298 (-4.36%) | 1.58% | $3 M | Nov 16, 2026 |
| 6 | Geode Capital Management, LLC | 48,927 | -709 (-1.43%) | 1.53% | $3 M | Nov 6, 2026 |
| 7 | State Street Corp | 38,698 | +7,388 (+23.60%) | 1.21% | $3 M | Nov 12, 2026 |
| 8 | D. E. Shaw & Co., Inc. | 37,484 | New | 1.17% | $3 M | Nov 16, 2026 |
| 9 | Jpmorgan Chase & Co | 32,540 | +253 (+0.78%) | 1.02% | $2 M | Nov 12, 2026 |
| 10 | Uniplan Investment Counsel, Inc. | 28,339 | New | 0.89% | $2 M | Nov 12, 2026 |
| 11 | Lazard Asset Management LLC | 23,537 | New | 0.74% | $2 M | Nov 16, 2026 |
| 12 | Pekin Hardy Strauss, Inc. | 22,800 | +6,300 (+38.18%) | 0.71% | $2 M | Nov 2, 2026 |
| 13 | Apriem Advisors | 20,070 | New | 0.63% | $1 M | Nov 16, 2026 |
| 14 | Goldman Sachs Group Inc | 19,945 | +1,234 (+6.60%) | 0.62% | $1 M | Nov 16, 2026 |
| 15 | Arrowstreet Capital, Limited Partnership | 17,393 | New | 0.54% | $1 M | Nov 13, 2026 |
| 16 | Ellsworth Advisors, LLC | 16,904 | New | 0.53% | $1 M | Oct 15, 2026 |
| 17 | Bank of New York Mellon Corp | 15,530 | +3,943 (+34.03%) | 0.49% | $1 M | Nov 5, 2026 |
| 18 | Northern Trust Corp | 15,528 | -87 (-0.56%) | 0.49% | $1 M | Nov 16, 2026 |
| 19 | Vanguard Portfolio Management LLC | 14,476 | +144 (+1.00%) | 0.45% | $1 M | Nov 13, 2026 |
| 20 | Quadrature Capital Ltd | 13,801 | New | 0.43% | $1 M | Nov 13, 2026 |
| 21 | Vanguard Fiduciary Trust Co | 12,493 | -807 (-6.07%) | 0.39% | $1 M | Nov 13, 2026 |
| 22 | Squarepoint Ops LLC | 11,656 | New | 0.36% | $1 M | Nov 9, 2026 |
| 23 | Russell Investments Group, Ltd. | 11,191 | +10,466 (+1443.59%) | 0.35% | $1 M | Nov 6, 2026 |
| 24 | Corsair Capital Management, L.P. | 10,835 | 0 (0.00%) | 0.34% | $1 M | Nov 16, 2026 |
| 25 | Morgan Stanley | 10,586 | +1,922 (+22.18%) | 0.33% | $1 M | Nov 13, 2026 |
Show all 85: investors 26 to 85
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | LPL Financial LLC | 10,562 | -3,735 (-26.12%) | 0.33% | $1 M | Nov 6, 2026 |
| 27 | Millennium Management LLC | 10,364 | +5,587 (+116.96%) | 0.32% | $1 M | Nov 16, 2026 |
| 28 | Bard Associates Inc | 9,893 | +94 (+0.96%) | 0.31% | $1 M | Nov 13, 2026 |
| 29 | O'shaughnessy Asset Management, LLC | 9,286 | +4,205 (+82.76%) | 0.29% | $1 M | Nov 12, 2026 |
| 30 | Osaic Holdings, Inc. | 8,780 | -280 (-3.09%) | 0.27% | $1 M | Nov 12, 2026 |
| 31 | BNP Paribas Financial Markets | 8,708 | -7,237 (-45.39%) | 0.27% | $1 M | Nov 12, 2026 |
| 32 | Acadian Asset Management LLC | 8,338 | +8,079 (+3119.31%) | 0.26% | $1 M | Nov 9, 2026 |
| 33 | Point72 Asset Management, L.P. | 8,200 | New | 0.26% | $1 M | Nov 16, 2026 |
| 34 | First Trust Advisors LP | 7,487 | +1,553 (+26.17%) | 0.23% | $1 M | Nov 12, 2026 |
| 35 | Ritholtz Wealth Management | 7,288 | +2,668 (+57.75%) | 0.23% | $1 M | Nov 5, 2026 |
| 36 | HRT Financial LP | 7,070 | -2,444 (-25.69%) | 0.22% | $0 M | Nov 13, 2026 |
| 37 | Charles Schwab Investment Management Inc | 6,567 | -514 (-7.26%) | 0.21% | $0 M | Nov 16, 2026 |
| 38 | Qube Research & Technologies Ltd | 6,500 | New | 0.20% | $0 M | Nov 13, 2026 |
| 39 | Nuveen, LLC | 5,367 | -3,880 (-41.96%) | 0.17% | $0 M | Nov 10, 2026 |
| 40 | Morgan Dempsey Capital Management LLC | 5,190 | -1,526 (-22.72%) | 0.16% | $0 M | Nov 13, 2026 |
| 41 | Ameriprise Financial Inc | 5,174 | New | 0.16% | $0 M | Nov 16, 2026 |
| 42 | Navellier & Associates Inc | 5,138 | -358 (-6.51%) | 0.16% | $0 M | Nov 12, 2026 |
| 43 | Bridgeway Capital Management, LLC | 5,000 | New | 0.16% | $0 M | Nov 16, 2026 |
| 44 | Integrated Quantitative Investments LLC | 4,709 | New | 0.15% | $0 M | Nov 13, 2026 |
| 45 | UBS Group AG | 4,280 | -352 (-7.60%) | 0.13% | $0 M | Nov 10, 2026 |
| 46 | Strs Ohio | 4,100 | New | 0.13% | $0 M | Oct 30, 2026 |
| 47 | AQR Capital Management LLC | 3,616 | New | 0.11% | $0 M | Nov 16, 2026 |
| 48 | Greenhaven Road Investment Management, L.P. | 3,585 | 0 (0.00%) | 0.11% | $0 M | Nov 13, 2026 |
| 49 | Alliancebernstein L.P. | 3,500 | New | 0.11% | $0 M | Nov 16, 2026 |
| 50 | NewEdge Advisors, LLC | 3,004 | New | 0.09% | $0 M | Nov 13, 2026 |
| 51 | James Investment Research, Inc. | 3,000 | New | 0.09% | $0 M | Oct 22, 2026 |
| 52 | Focus Financial Network, Inc. | 3,000 | New | 0.09% | $0 M | Oct 14, 2026 |
| 53 | Jain Global LLC | 2,905 | New | 0.09% | $0 M | Nov 16, 2026 |
| 54 | Vanguard Global Advisers, LLC | 2,690 | +1,666 (+162.70%) | 0.08% | $0 M | Nov 13, 2026 |
| 55 | Los Angeles Capital Management LLC | 2,650 | New | 0.08% | $0 M | Nov 12, 2026 |
| 56 | Rhumbline Advisers | 2,476 | +974 (+64.85%) | 0.08% | $0 M | Nov 10, 2026 |
| 57 | Royal Bank Of Canada | 1,765 | +455 (+34.73%) | 0.06% | $0 M | Nov 16, 2026 |
| 58 | Deutsche Bank AG\ | 1,613 | -218 (-11.91%) | 0.05% | $0 M | Nov 6, 2026 |
| 59 | Citigroup Inc | 1,264 | +291 (+29.91%) | 0.04% | $0 M | Nov 4, 2026 |
| 60 | New York State Common Retirement Fund | 1,090 | 0 (0.00%) | 0.03% | $0 M | Nov 17, 2026 |
| 61 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 1,005 | +50 (+5.24%) | 0.03% | $0 M | Nov 16, 2026 |
| 62 | Barclays PLC | 768 | +463 (+151.80%) | 0.02% | $0 M | Nov 6, 2026 |
| 63 | Police & Firemen's Retirement System of New Jersey | 637 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 64 | Wells Fargo & Company/mn | 630 | -1,261 (-66.68%) | 0.02% | $0 M | Nov 16, 2026 |
| 65 | FMR LLC | 374 | +118 (+46.09%) | 0.01% | $0 M | Nov 10, 2026 |
| 66 | Lavaca Capital LLC | 240 | -113 (-32.01%) | 0.01% | $0 M | Nov 16, 2026 |
| 67 | Ameritas Investment Partners, Inc. | 216 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 68 | Legal & General Group Plc | 192 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 69 | Tower Research Capital LLC (TRC) | 175 | -175 (-50.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 70 | Arax Advisory Partners | 126 | -85 (-40.28%) | 0.00% | $0 M | Nov 12, 2026 |
| 71 | Ascentis Independent Advisors | 120 | New | 0.00% | $0 M | Nov 3, 2026 |
| 72 | Harbour Investments, Inc. | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 9, 2026 |
| 73 | PNC Financial Services Group, Inc. | 96 | +70 (+269.23%) | 0.00% | $0 M | Nov 6, 2026 |
| 74 | Sterling Capital Management LLC | 68 | +61 (+871.43%) | 0.00% | $0 M | Oct 22, 2026 |
| 75 | Hurley Capital, LLC | 60 | 0 (0.00%) | 0.00% | $0 M | Nov 5, 2026 |
| 76 | Allworth Financial LP | 35 | +29 (+483.33%) | 0.00% | $0 M | Nov 17, 2026 |
| 77 | SJS Investment Consulting Inc. | 33 | +29 (+725.00%) | 0.00% | $0 M | Oct 26, 2026 |
| 78 | California State Teachers Retirement System | 29 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 79 | GAMMA Investing LLC | 18 | 0 (0.00%) | 0.00% | $0 M | Oct 8, 2026 |
| 80 | Root Financial Partners, LLC | 12 | New | 0.00% | $0 M | Oct 21, 2026 |
| 81 | Farther Finance Advisors, LLC | 10 | -1 (-9.09%) | 0.00% | $0 M | Oct 8, 2026 |
| 82 | Physician Wealth Advisors, Inc. | 9 | New | 0.00% | $0 M | Oct 20, 2026 |
| 83 | Essential Partners LLC | 7 | 0 (0.00%) | 0.00% | $0 M | Oct 14, 2026 |
| 84 | EverSource Wealth Advisors, LLC | 2 | -1 (-33.33%) | 0.00% | $0 M | Nov 4, 2026 |
| 85 | True Wealth Design, LLC | 1 | 0 (0.00%) | 0.00% | $0 M | Oct 13, 2026 |
Mutual funds holding Pro-Dex, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 60,523 | $4 M | 1.9% | <0.01% | −32% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 53,550 | $3 M | 1.7% | <0.01% | −4.9% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 22,677 | $1 M | 0.71% | <0.01% | +9.8% | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 21,926 | $1 M | 0.69% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 20,554 | $1 M | 0.64% | <0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 19,706 | $1 M | 0.62% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 10,648 | $1 M | 0.33% | <0.01% | +1.7% | May 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 9,341 | $1 M | 0.29% | <0.01% | −6.2% | May 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 8,195 | $0 M | 0.26% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 7,809 | $0 M | 0.24% | <0.01% | +2.5% | Jul 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 6,982 | $0 M | 0.22% | 0.03% | +33% | Jun 30, 2026 |
| 🇺🇸 First Trust Dow Jones Select MicroCap Index FundFirst Trust Advisors L.P. | 5,934 | $0 M | 0.19% | 0.13% | +3.9% | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 5,165 | $0 M | 0.16% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP | 5,042 | $0 M | 0.16% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP | 4,857 | $0 M | 0.15% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 4,064 | $0 M | 0.13% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 3,665 | $0 M | 0.11% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 3,580 | $0 M | 0.11% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 3,119 | $0 M | 0.10% | 0.02% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 2,777 | $0 M | 0.09% | <0.01% | −7.5% | May 31, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 2,883 | $0 M | 0.09% | 0.05% | no change | Jul 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 2,739 | $0 M | 0.09% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 2,725 | $0 M | 0.09% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 2,354 | $0 M | 0.07% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 2,200 | $0 M | 0.07% | <0.01% | +57% | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 1,984 | $0 M | 0.06% | <0.01% | −42% | May 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 1,974 | $0 M | 0.06% | <0.01% | +236% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 1,909 | $0 M | 0.06% | <0.01% | −4.2% | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 1,926 | $0 M | 0.06% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 1,916 | $0 M | 0.06% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 1,500 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 1,452 | $0 M | 0.05% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 1,300 | $0 M | 0.04% | <0.01% | +160% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust | 1,065 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 1,148 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 1,002 | $0 M | 0.03% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 972 | $0 M | 0.03% | <0.01% | −7.3% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 860 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 906 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP | 810 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 700 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 643 | $0 M | 0.02% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP | 640 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 558 | $0 M | 0.02% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 556 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc. | 550 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 478 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 467 | $0 M | 0.01% | 0.01% | +23% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 424 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 392 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP | 344 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 338 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 302 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 300 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 328 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 313 | $0 M | <0.01% | <0.01% | +57% | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 307 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 261 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 240 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 233 | $0 M | <0.01% | <0.01% | +0.9% | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 216 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 212 | $0 M | <0.01% | <0.01% | +48% | Jun 30, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 184 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 179 | $0 M | <0.01% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 175 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 100 | $0 M | <0.01% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Value FundAmerican Century ETF Trust | 100 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 98 | $0 M | <0.01% | <0.01% | +4.3% | May 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 108 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 79 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 79 | $0 M | <0.01% | <0.01% | −41% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 77 | $0 M | <0.01% | <0.01% | −41% | May 31, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 36 | $0 M | <0.01% | <0.01% | −51% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 12 | $0 M | <0.01% | <0.01% | +20% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 74 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Pro-Dex, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -290 | $58.94 | $17 K | 79,703 | Form 4 |
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -475 | $59.62 | $28 K | 79,228 | Form 4 |
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -2,160 | $58.92 | $127 K | 97,068 | Form 4 |
| filed | Alisha CharltonChief Financial Officer | Sell | -1,500 | $61.05 | $92 K | 22,670 | Form 4 |
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -2,691 | $59.84 | $161 K | 94,377 | Form 4 |
| filed | Alisha CharltonChief Financial Officer | Sell | -800 | $61.76 | $49 K | 21,870 | Form 4 |
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -4,274 | $60.72 | $260 K | 90,103 | Form 4 |
| filed | Richard Lee Van Kirk Jr.Chief Executive Officer, Director | Sell10b5-1 plan | -1,157 | $61.88 | $72 K | 88,946 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Pro-Dex, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q1 2027 | $0.6M |
| Q2 2026 | Q4 2026 | $0.6M |
| Q1 2026 | Q3 2026 | $0.6M |
| Q2 2025 | Q4 2025 | $0M |
| Q1 2025 | Q3 2025 | $0M |
| Q4 2024 | Q2 2025 | $1.2M |
| Q3 2024 | Q1 2025 | $2.3M |
| Q2 2024 | Q4 2024 | $1.7M |
| Q1 2024 | Q3 2024 | $1.7M |
| Q2 2023 | Q4 2023 | $0M |
| Q1 2023 | Q3 2023 | $0.2M |
| Q4 2022 | Q2 2023 | $1M |
| Q3 2022 | Q1 2023 | $0.4M |
| Q2 2022 | Q4 2022 | $0.4M |
| Q1 2022 | Q3 2022 | $0.6M |
| Q4 2021 | Q2 2022 | $0.6M |
Trading halts
- 2025-05-02 13:34 UTC, code LUDP, resumed 13:39 UTC
Fails to deliver
- : 1,406 shares at $62.27
- : 222 shares at $57.70
- : 92 shares at $58.26
- : 364 shares at $60.02
- : 638 shares at $59.82
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Pro-Dex, Inc. scorecard#
Passes 22 of the 27 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (3 of 6). Fiscal year 2026; market cap of Oct 28, 2026.
Valuation3 of 6
- ✓P/E below its peers' median16.6×P/E 16.6× against Medical Instruments's median of 32.6×.
- ✗Price to book below its peers' median4.2×Price to book 4.2× against Medical Instruments's median of 3.9×.
- ✓Price to sales below its peers' median2.5×Price to sales 2.5× against Medical Instruments's median of 3.0×.
- ✗Free cash flow yield above 5%3.4%Free cash flow is 3.4% of the market value.
- ✓Earnings yield above the 10-year Treasury yield6.0%Earnings yield 6.0% against the 10-year Treasury's 5.15% on 2026-11-13.
- ✗The price assumes slower growth than the last three years'31.5%The price assumes 31.5% a year for ten years; revenue grew 18.9% a year over the last three.
Growth6 of 6
- ✓Revenue grew in the newest year16.5%Revenue up 16.5% in fiscal 2026.
- ✓Revenue up more than 5% a year over three years18.9%18.9% a year over the three years to fiscal 2026.
- ✓Faster growth over three years than its peers' median18.9%18.9% a year against Medical Instruments's median of 5.0% (37 companies).
- ✓Earnings per share grew in the newest year4.12 vs 2.67Diluted EPS 4.12 in fiscal 2026 against 2.67 the year before (report's currency).
- ✓Net income higher than five years earlier$14 M$14 M in fiscal 2026 against $6 M in 2021.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2026.
Profitability6 of 6
- ✓Profitable in the newest year$14 MNet income $14 M in fiscal 2026.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2026.
- ✓Operating margin above its peers' median16.8%16.8% against Medical Instruments's median of 7.2% (46 companies).
- ✓Return on equity above 15%32.4%32.4% in fiscal 2026.
- ✓Return on invested capital above 10%18.1%18.1% in fiscal 2026.
- ✓Operating margin wider than three years earlier16.8%16.8% in fiscal 2026 against 12.5% in 2023.
Financial health5 of 6
- ✓Short-term assets cover short-term liabilities4.1×Current ratio 4.10 at the end of fiscal 2026.
- ✓Debt below equity0.4×Debt to equity 0.37 at the end of fiscal 2026.
- ✓Net debt below three years of EBITDA0.7×Net debt 0.7 times EBITDA in fiscal 2026.
- ✓Operating income covers interest five times16.0×Operating income 16.0 times interest in fiscal 2026.
- ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2026.
- ✓Altman Z-score outside the distress zone7.61Z-score 7.61 (safe zone) for fiscal 2026.
Shareholder returns2 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-1.3%Diluted shares down 1.3% in fiscal 2026.
- ✗Dividends and buybacks above 3% of the market value1.7%Dividends and buybacks were 1.7% of the market value.
- ✓Free cash flow covers dividends and buybacks$7 MFree cash flow $7 M against $3 M paid out in fiscal 2026.
Worked out from the statements as filed (sec), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2026#
Worked out from Pro-Dex, Inc.'s statements, beside the median of Medical Instruments.
| Ratio | Trend | 2026 | Median of peers |
|---|---|---|---|
| Operating margin | 16.8% | 7.2% | |
| Net margin | 17.6% | 3.8% | |
| Return on equity | 32.4% | 3.5% | |
| Revenue growth, 3 years a year | 18.9% | 5.0% | |
| Revenue growth | 16.5% | 8.9% | |
| Debt to equity | 0.37× | 0.46× |
7of 9on the Piotroski tests of financial strength
- Revenue has grown 12 years in a row.
Pro-Dex, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2026to Jun 30, 2026 | FY 2025to Jun 30, 2025 | FY 2024to Jun 30, 2024 | FY 2023to Jun 30, 2023 | FY 2022to Jun 30, 2022 | FY 2021to Jun 30, 2021 | FY 2020to Jun 30, 2020 | FY 2019to Jun 30, 2019 | FY 2018to Jun 30, 2018 | FY 2017to Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 77,548+16.5%100% | 66,593+23.7%100% | 53,844+16.8%100% | 46,087+9.6%100% | 42,041+10.5%100% | 38,029+9.2%100% | 34,834+28.2%100% | 27,172+21.0%100% | 22,465+2.4%100% | 21,943—100% | |
| Cost of revenue | 53,213+13.0%68.6% | 47,083+19.8%70.7% | 39,293+17.9%73.0% | 33,338+15.3%72.3% | 28,909+18.2%68.8% | 24,454+12.7%64.3% | 21,692+24.7%62.3% | 17,392+19.8%64.0% | 14,522−1.6%64.6% | 14,757—67.3% | |
| Gross profit | 24,335+24.7%31.4% | 19,510+34.1%29.3% | 14,551+14.1%27.0% | 12,749−2.9%27.7% | 13,132−3.3%31.2% | 13,575+3.3%35.7% | 13,142+34.4%37.7% | 9,780+23.1%36.0% | 7,943+10.5%35.4% | 7,186—32.7% | |
| Research and development | 3,345−8.0%4.3% | 3,636+14.0%5.5% | 3,189+13.7%5.9% | 2,804−5.9%6.1% | 2,980−32.0%7.1% | 4,384+89.4%11.5% | 2,315+23.0%6.6% | 1,882−0.6%6.9% | 1,893+54.5%8.4% | 1,225—5.6% | |
| Selling, general and administrative | 7,999+54.3%10.3% | 5,185—7.8% | — | — | — | — | — | — | — | — | |
| Selling and marketing | — | 344+194%0.5% | 117−24.5%0.2% | 155+70.3%0.3% | 91−84.6%0.2% | 590+2.3%1.6% | 577+39.0%1.7% | 415+15.9%1.5% | 358−38.8%1.6% | 585—2.7% | |
| General and administrative | — | 4,841+18.9%7.3% | 4,072+1.1%7.6% | 4,028−17.8%8.7% | 4,903+20.3%11.7% | 4,076+27.8%10.7% | 3,189+28.0%9.2% | 2,492+9.0%9.2% | 2,287−9.6%10.2% | 2,529—11.5% | |
| Operating expenses | 11,344+28.6%14.6% | 8,821+19.6%13.2% | 7,378+5.6%13.7% | 6,987−12.8%15.2% | 8,009−11.5%19.1% | 9,050+48.9%23.8% | 6,076+27.1%17.4% | 4,782−13.9%17.6% | 5,551+24.8%24.7% | 4,449r4,452—20.3% | |
| Operating income | 12,991+21.5%16.8% | 10,689+49.0%16.1% | 7,173+24.5%13.3% | 5,762+12.5%12.5% | 5,123+13.2%12.2% | 4,525−36.0%11.9% | 7,066+41.4%20.3% | 4,998+109%18.4% | 2,392−12.6%10.6% | 2,737r2,734—12.5% | |
| Interest and finance income | 181+121%0.2% | 82−43.1%0.1% | 144−51.0%0.3% | 294+287%0.6% | 76−39.7%0.2% | 126+32.6%0.3% | 95−64.6%0.3% | 268+19.1%1.0% | 225+733%1.0% | 27—0.1% | |
| Interest expense and finance costs | 812−2.1%1.0% | 829+48.6%1.2% | 558+4.7%1.0% | 533+14.9%1.2% | 464+31.8%1.1% | 352+49.2%0.9% | 236+7.3%0.7% | 220+3043%0.8% | 7.0−41.7%0.0% | 12—0.1% | |
| Share of profit of associates | — | — | — | — | 61—0.1% | — | — | — | — | — | |
| Other non-operating income (expense) | 5,024+267%6.5% | 1,369—2.1% | −4,539−224%−8.4% | 3,666+542%8.0% | 571r−417−81.5%1.4% | 3,091r1,101+270%8.1% | 836+86.2%2.4% | 449+106%1.7% | 218+1353%1.0% | 15r18—0.1% | |
| Income before tax | 18,015+49.4%23.2% | 12,058+358%18.1% | 2,634−72.1%4.9% | 9,428+65.6%20.5% | 5,694r4,706−25.2%13.5% | 7,616r5,626−3.6%20.0% | 7,902+45.1%22.7% | 5,447+109%20.0% | 2,610−5.2%11.6% | 2,752—12.5% | |
| Income tax | 4,353+41.3%5.6% | 3,080+507%4.6% | 507−78.5%0.9% | 2,354+110%5.1% | 1,122r851−22.4%2.7% | 1,446r1,176−19.2%3.8% | 1,790+37.8%5.1% | 1,299+31.3%4.8% | 989—4.4% | −2,089—−9.5% | |
| Income from continuing operations | — | — | — | — | — | — | — | — | 1,621−66.5%7.2% | 4,841—22.1% | |
| Income from discontinued operations | — | — | — | — | — | — | — | — | — | 243—1.1% | |
| Net income including minority interests | 0−100%0.0% | 155+31.4%0.2% | 118+9.3%0.2% | 108—0.2% | 0−100%0.0% | 71−80.8%0.2% | 370—1.1% | — | — | — | |
| Net income attributable to shareholders | 13,662+52.2%17.6% | 8,978+322%13.5% | 2,127−69.9%4.0% | 7,074+54.7%15.3% | 4,572r3,855−25.9%10.9% | 6,170r4,450+0.9%16.2% | 6,112+47.3%17.5% | 4,148+156%15.3% | 1,621−68.1%7.2% | 5,084—23.2% | |
| Earnings per share, basic | 4.24+55.3%— | 2.73+348%— | 0.61−69.2%— | 1.98+57.1%— | 1.26r1.06−22.7%— | 1.63r1.17+4.5%— | 1.56+57.6%— | 0.99+161%— | 0.38−69.8%— | 1.26—— | |
| Earnings per share, diluted | 4.12+54.3%— | 2.67+345%— | 0.60−69.2%— | 1.95+61.2%— | 1.21r1.02−22.9%— | 1.57r1.13+4.7%— | 1.50+54.6%— | 0.97+162%— | 0.37−70.4%— | 1.25—— | |
| Shares, weighted average (basic) | 3.2−1.9%— | 3.3−6.0%— | 3.5−2.0%— | 3.6−1.8%— | 3.6−4.2%— | 3.8−2.9%— | 3.9−6.7%— | 4.2−2.6%— | 4.3+6.5%— | 4.0—— | |
| Shares, weighted average (diluted) | 3.3−1.3%— | 3.4−5.9%— | 3.6−1.8%— | 3.6−3.4%— | 3.8−4.4%— | 3.9−3.5%— | 4.1−5.1%— | 4.3−1.1%— | 4.3+6.6%— | 4.1—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 8,192+1855%11.0% | 419r419−84.1%0.7% | 2,631r2,631−10.4%5.0% | 2,936+246%5.7% | 849−77.2%1.7% | 3,721−42.0%9.2% | 6,421−17.1%20.6% | 7,742+49.2%30.3% | 5,188+23.4%26.0% | 4,205—25.7% | |
| Short-term investments | 1,150−82.9%1.5% | 6,740+59.8%11.0% | 4,217+272%8.0% | 1,134+50.2%2.2% | 755−41.7%1.5% | 1,295r1,295−49.4%3.2% | 2,560+49.6%8.2% | 1,711r2,649−22.9%6.7% | 2,220+209%11.1% | 718—4.4% | |
| Receivables | 21,205+29.0%28.5% | 16,433+18.3%26.9% | 13,887+39.5%26.5% | 9,952−35.3%19.2% | 15,384+40.7%31.3% | 10,933+112%27.1% | 5,155+25.7%16.6% | 4,100+38.7%16.1% | 2,955−16.5%14.8% | 3,538—21.6% | |
| Inventory | 21,458−3.4%28.8% | 22,213+45.5%36.3% | 15,269−5.6%29.1% | 16,167+27.5%31.2% | 12,678+50.3%25.8% | 8,437+2.4%20.9% | 8,238+32.0%26.5% | 6,239+42.0%24.4% | 4,393+42.4%22.1% | 3,084r3,085—18.9% | |
| Other current assets | — | 410+18.8%0.7% | 345+16.6%0.7% | 296−62.5%0.6% | 790+82.0%1.6% | 434+199%1.1% | 145−76.7%0.5% | 623+132%2.4% | 269−25.9%1.4% | 363—2.2% | |
| Current assets | 53,248+12.6%71.5% | 47,295+29.2%77.3% | 36,611+18.2%69.8% | 30,979−0.6%59.8% | 31,166+24.6%63.5% | 25,013+10.3%62.0% | 22,674+8.8%72.8% | 20,845r21,783+28.4%81.7% | 16,233+32.2%81.5% | 12,283r11,921—75.1% | |
| Property, plant and equipment | 5,373+4.3%7.2% | 5,153+2.6%8.4% | 5,024r5,024−1.1%9.6% | 5,079+5.1%9.8% | 4,833+25.7%9.8% | 3,845+43.1%9.5% | 2,686−1.5%8.6% | 2,726+55.3%10.7% | 1,755+30.0%8.8% | 1,350r1,429—8.3% | |
| Right-of-use (leased) assets | 602−42.7%0.8% | 1,050−28.7%1.7% | 1,473−21.3%2.8% | 1,872−16.7%3.6% | 2,248−13.7%4.6% | 2,605−11.5%6.5% | 2,943—9.5% | — | — | — | |
| Goodwill | 6,525—8.8% | — | — | — | — | — | — | — | — | 112—0.7% | |
| Other intangible assets | 686+2538%0.9% | 26−51.9%0.0% | 54−33.3%0.1% | 81−31.4%0.2% | 118−36.6%0.2% | 186+14.8%0.5% | 162+25.6%0.5% | 129−7.9%0.5% | 140−6.0%0.7% | 149r320—0.9% | |
| Long-term investments | 504+241%0.7% | 148−90.5%0.2% | 1,563−79.2%3.0% | 7,521+84.2%14.5% | 4,083r1,779+140%8.3% | 1,704−27.8%4.2% | 2,360+55.3%7.6% | 1,520r582—6.0% | — | — | |
| Total assets | 74,509+21.8%100% | 61,192+16.6%100% | 52,477+1.3%100% | 51,823+5.6%100% | 49,089r47,326+21.7%100% | 40,320+29.5%100% | 31,126+22.0%100% | 25,520+28.1%100% | 19,917+21.8%100% | 16,351—100% | |
| Accounts payable | 4,262−7.6%5.7% | 4,614+2.2%7.5% | 4,513+99.6%8.6% | 2,261−39.9%4.4% | 3,761+64.4%7.7% | 2,288+16.4%5.7% | 1,965−1.6%6.3% | 1,996+84.3%7.8% | 1,083−6.6%5.4% | 1,159—7.1% | |
| Debt due within a year | — | — | — | — | — | 1,236+89.9%3.1% | 651+4.7%2.1% | 622+1677%2.4% | 35−39.7%0.2% | 58—0.4% | |
| Current liabilities | 12,983−11.3%17.4% | 14,629+13.5%23.9% | 12,892+33.2%24.6% | 9,676−14.8%18.7% | 11,354+81.1%23.1% | 6,269r5,872+19.9%15.5% | 5,227+22.4%16.8% | 4,270+76.8%16.7% | 2,415r2,538−6.4%12.1% | 2,580—15.8% | |
| Long-term debt | — | — | — | — | — | 11,535+251%28.6% | 3,283−16.5%10.5% | 3,934+65467%15.4% | 6.0−90.2%0.0% | 61—0.4% | |
| Lease liabilities (non-current) | 627−8.5%0.8% | 685−42.0%1.1% | 1,182−27.8%2.3% | 1,638−20.3%3.2% | 2,054−15.5%4.2% | 2,432−11.6%6.0% | 2,750—8.8% | — | — | — | |
| Non-current liabilities | 13,893+39.9%18.6% | 9,931+13.9%16.2% | 8,718−17.4%16.6% | 10,557−14.2%20.4% | 12,304−11.9%25.1% | 13,967r14,364+104%34.6% | 6,837+61.2%22.0% | 4,242+1777%16.6% | 226r103+270%1.1% | 61—0.4% | |
| Total liabilities | 26,876+9.4%36.1% | 24,560+13.7%40.1% | 21,610+6.8%41.2% | 20,233−14.5%39.0% | 23,658+16.9%48.2% | 20,236+67.7%50.2% | 12,064+41.7%38.8% | 8,512+222%33.4% | 2,6410.0%13.3% | 2,641—16.2% | |
| Retained earnings | 47,633+32.6%63.9% | 35,928+33.3%58.7% | 26,950+8.6%51.4% | 24,823+39.9%47.9% | 17,749r15,986+46.3%36.2% | 12,131r12,346+53.6%30.1% | 7,896+353%25.4% | 1,742—6.8% | −2,406—−12.1% | −4,027—−24.6% | |
| Shareholders' equity | 47,633+30.0%63.9% | 36,632+18.7%59.9% | 30,867−2.3%58.8% | 31,590+24.2%61.0% | 25,431r23,668+20.4%51.8% | 21,130r20,084+10.8%52.4% | 19,062+12.1%61.2% | 17,008−1.6%66.6% | 17,276+26.0%86.7% | 13,710—83.8% | |
| Total liabilities and equity | 74,509+21.8%100% | 61,192+16.6%100% | 52,477+1.3%100% | 51,823+5.6%100% | 49,089r47,326+21.7%100% | 40,320+29.5%100% | 31,126+22.0%100% | 25,520+28.1%100% | 19,917+21.8%100% | 16,351—100% | |
| Shares outstanding | 3.2−2.3%— | 3.3−3.0%— | 3.4−5.1%— | 3.5−1.4%— | 3.6−1.4%— | 3.60.0%— | 3.6r3.8−9.7%— | 4.0−6.7%— | 4.3+7.6%— | 4.0—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 1,394+12.5%1.8% | 1,239+6.8%1.9% | 1,160+35.4%2.2% | 857+18.0%1.9% | 726+5.8%1.7% | 686+19.7%1.8% | 573+30.8%1.6% | 438−21.4%1.6% | 557+0.4%2.5% | 555—2.5% | |
| Share-based compensation | 688+24.0%0.9% | 555−8.3%0.8% | 605−21.0%1.1% | 766−39.9%1.7% | 1,275+41.5%3.0% | 901+215%2.4% | 286+673%0.8% | 37−80.9%0.1% | 194+6367%0.9% | 3.0—0.0% | |
| Cash from operating activities | 7,242—9.3% | −1,682−127%−2.5% | 6,224r6,199+14.0%11.6% | 5,462—11.9% | −847—−2.0% | −2,078−142%−5.5% | 4,945+48.7%14.2% | 3,326+7.4%12.2% | 3,096−4.3%13.8% | 3,235—14.7% | |
| Capital expenditure | −483—−0.6% | −1,246—−1.9% | — | — | −1,638—−3.9% | −1,769—−4.7% | −519—−1.5% | −1,387—−5.1% | −923—−4.1% | −606—−2.8% | |
| Intangible assets bought | — | — | — | — | −33—−0.1% | −38—−0.1% | −46—−0.1% | −11—−0.0% | −11—−0.0% | −32—−0.1% | |
| Acquisitions, net of cash acquired | −6,493—−8.4% | — | — | — | — | — | — | — | — | — | |
| Cash from investing activities | 3,913—5.0% | −238—−0.4% | −2,233—−4.1% | −885—−1.9% | −1,235—−2.9% | −3,710—−9.8% | −2,287—−6.6% | −1,222—−4.5% | −4,115—−18.3% | −1,026—−4.7% | |
| Debt issued | — | — | — | 5,284+164%11.5% | 2,000−78.1%4.8% | 9,139—24.0% | — | 4,940—18.2% | — | — | |
| Shares issued | — | — | — | — | — | — | — | — | 2,262+4613%10.1% | 48—0.2% | |
| Shares bought back | −3,408—−4.4% | −3,504—−5.3% | −3,505—−6.5% | −1,547—−3.4% | −1,606—−3.8% | −5,537—−14.6% | −3,388—−9.7% | −3,984—−14.7% | −220—−1.0% | −312—−1.4% | |
| Cash from financing activities | −3,382—−4.4% | −292—−0.4% | −4,296r−4,271—−8.0% | −2,490—−5.4% | −790−126%−1.9% | 3,088—8.1% | −3,979−984%−11.4% | 450−77.5%1.7% | 2,002—8.9% | −298—−1.4% | |
| Change in cash | — | — | — | — | — | — | — | 2,554+160%9.4% | 983−48.6%4.4% | 1,911—8.7% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q1 FY2027to Sep 30, 2026 | Q4 FY2026to Jun 30, 2026 | Q3 FY2026to Mar 31, 2026 | Q2 FY2026to Dec 31, 2025 | Q1 FY2026to Sep 30, 2025 | Q4 FY2025to Jun 30, 2025 | Q3 FY2025to Mar 31, 2025 | Q2 FY2025to Dec 31, 2024 | Q1 FY2025to Sep 30, 2024 | Q4 FY2024to Jun 30, 2024 | Q3 FY2024to Mar 31, 2024 | Q2 FY2024to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 79,577+13.3%100% | 20,560+11.0%100% | 20,405*+16.6%100% | 19,949+14.6%100% | 18,663+11.1%100% | 18,530+24.4%100% | 17,494*+16.4%100% | 17,414+21.8%100% | 16,793+33.4%100% | 14,892—100% | 15,025*—100% | 14,293—100% | 12,588—100% | |
| Cost of revenue | 53,753+6.4%67.5% | 13,703+4.1%66.6% | 13,314*−4.9%65.2% | 13,816+18.9%69.3% | 12,920+10.2%69.2% | 13,163+35.1%71.0% | 14,003*+28.0%80.0% | 11,616+12.9%66.7% | 11,721+19.8%69.8% | 9,742—65.4% | 10,936*—72.8% | 10,291—72.0% | 9,786—77.7% | |
| Gross profit | 25,824+30.9%32.5% | 6,857+27.8%33.4% | 7,091*+103%34.8% | 6,133+5.8%30.7% | 5,743+13.2%30.8% | 5,367+4.2%29.0% | 3,491*−14.6%20.0% | 5,798+44.9%33.3% | 5,072+81.0%30.2% | 5,150—34.6% | 4,089*—27.2% | 4,002—28.0% | 2,802—22.3% | |
| Research and development | 3,788+6.3%4.8% | 1,210+57.6%5.9% | 1,017*+12.4%5.0% | 827−12.7%4.1% | 734−22.1%3.9% | 768−8.9%4.1% | 905*+8.3%5.2% | 947+24.6%5.4% | 942+19.5%5.6% | 843—5.7% | 836*—5.6% | 760—5.3% | 788—6.3% | |
| Selling, general and administrative | 8,639+60.5%10.9% | 2,132+43.1%10.4% | 2,545*+105%12.5% | 2,212+82.7%11.1% | 1,750+21.7%9.4% | 1,490—8.0% | 1,242*—7.1% | 1,211—7.0% | 1,438—8.6% | — | — | — | — | |
| Selling and marketing | — | — | — | — | — | 73+52.1%0.4% | 133*+250%0.8% | 113+565%0.6% | 49+32.4%0.3% | 48—0.3% | 38*—0.3% | 17—0.1% | 37—0.3% | |
| General and administrative | — | — | — | — | — | 1,417+13.7%7.6% | 1,109*+28.4%6.3% | 1,098+8.5%6.3% | 1,389+15.7%8.3% | 1,246—8.4% | 864*—5.8% | 1,012—7.1% | 1,200—9.5% | |
| Operating expenses | 12,427+39.0%15.6% | 3,342+48.0%16.3% | 3,562*+65.9%17.5% | 3,039+40.8%15.2% | 2,484+4.4%13.3% | 2,258+5.7%12.2% | 2,147*+23.5%12.3% | 2,158+20.6%12.4% | 2,380+17.5%14.2% | 2,137—14.3% | 1,738*—11.6% | 1,789—12.5% | 2,025—16.1% | |
| Operating income | 13,397+24.2%16.8% | 3,515+13.1%17.1% | 3,529*+163%17.3% | 3,094−15.0%15.5% | 3,259+21.1%17.5% | 3,109+3.2%16.8% | 1,344*−42.8%7.7% | 3,640+64.5%20.9% | 2,692+246%16.0% | 3,013—20.2% | 2,351*—15.6% | 2,213—15.5% | 777—6.2% | |
| Interest and finance income | — | 51+264%0.2% | — | — | — | 14−44.0%0.1% | — | — | — | 25—0.2% | — | — | — | |
| Interest expense and finance costs | — | 260+30.0%1.3% | — | 201−18.3%1.0% | 141−30.9%0.8% | 200+31.6%1.1% | — | 246+78.3%1.4% | 204+46.8%1.2% | 152—1.0% | — | 138—1.0% | 139—1.1% | |
| Other non-operating income (expense) | — | −136−104%−0.7% | — | — | −331—−1.8% | 3,113+917%16.8% | — | 15−50.0%0.1% | −106r21−582%−0.6% | 306—2.1% | — | 30—0.2% | 22—0.2% | |
| Income before tax | 15,172+1.4%19.1% | 3,379−45.7%16.4% | 3,525*+120%17.3% | 5,340+17.3%26.8% | 2,928+13.2%15.7% | 6,222+87.5%33.6% | 1,599*−17.2%9.1% | 4,554+399%26.2% | 2,586+317%15.4% | 3,319—22.3% | 1,930*—12.8% | 913—6.4% | 620—4.9% | |
| Income tax | 3,142−16.6%3.9% | 331−78.5%1.6% | 668*+66.2%3.3% | 1,402+9.6%7.0% | 741+35.7%4.0% | 1,542+80.8%8.3% | 402*+17.2%2.3% | 1,279+396%7.3% | 546+355%3.3% | 853—5.7% | 343*—2.3% | 258—1.8% | 120—1.0% | |
| Net income including minority interests | — | — | — | — | — | — | — | — | — | — | −422*—−2.8% | 655*—4.6% | — | |
| Net income attributable to shareholders | 12,030+7.5%15.1% | 3,048−34.9%14.8% | 2,857*+139%14.0% | 3,938+20.2%19.7% | 2,187+7.2%11.7% | 4,680+89.8%25.3% | 1,197*−24.6%6.8% | 3,275+400%18.8% | 2,040+308%12.1% | 2,466—16.6% | 1,587*—10.6% | 655—4.6% | 500—4.0% | |
| Earnings per share, basic | — | 0.95−33.6%— | — | 1.23+23.0%— | 0.67+6.3%— | 1.43+88.2%— | — | 1.00+426%— | 0.63+350%— | 0.76—— | — | 0.19—— | 0.14—— | |
| Earnings per share, diluted | — | 0.92−34.3%— | — | 1.20+22.4%— | 0.66+8.2%— | 1.40+86.7%— | — | 0.98+416%— | 0.61+336%— | 0.75—— | — | 0.19—— | 0.14—— | |
| Shares, weighted average (basic) | 3.2−1.7%— | 3.2−1.7%— | — | 3.2−1.8%— | 3.2−0.4%— | 3.3+0.1%— | — | 3.3−5.5%— | 3.3−8.1%— | 3.3—— | — | 3.5r0.0—— | 3.5r3.5—— | |
| Shares, weighted average (diluted) | 3.3−0.7%— | 3.3−0.7%— | — | 3.3−2.0%— | 3.3−1.0%— | 3.3+1.4%— | — | 3.3−5.3%— | 3.3−7.6%— | 3.3—— | — | 3.5r0.0—— | 3.6r3.6—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 11,759—15.4% | 11,759+35533%15.4% | 8,192+1855%11.0% | 6,627+19982%8.8% | 5,273+7889%8.5% | 33−98.9%0.1% | 419r419−84.1%0.7% | 33−99.0%0.1% | 66−94.9%0.1% | 3,081—5.7% | 2,631r2,631—5.0% | 3,219—6.4% | 1,289—2.5% | |
| Short-term investments | 1,230—1.6% | 1,230−87.7%1.6% | 1,150−82.9%1.5% | 986−81.8%1.3% | 864−81.5%1.4% | 10,038+112%15.6% | 6,740+59.8%11.0% | 5,417+18.4%8.4% | 4,671−19.5%7.7% | 4,738—8.7% | 4,217—8.0% | 4,577—9.1% | 5,803—11.3% | |
| Receivables | 17,507—22.9% | 17,507−4.0%22.9% | 21,205+29.0%28.5% | 19,473+22.8%26.0% | 17,883−3.2%28.7% | 18,234+35.5%28.4% | 16,433+18.3%26.9% | 15,861+26.7%24.7% | 18,467+40.2%30.6% | 13,456—24.8% | 13,887—26.5% | 12,516—24.8% | 13,169—25.6% | |
| Inventory | 21,899—28.6% | 21,899+1.6%28.6% | 21,458−3.4%28.8% | 22,357−4.6%29.8% | 21,710+10.7%34.9% | 21,564+29.9%33.5% | 22,213+45.5%36.3% | 23,432+64.5%36.5% | 19,611+30.5%32.5% | 16,604—30.6% | 15,269—29.1% | 14,242—28.2% | 15,026—29.2% | |
| Other current assets | — | — | — | 560−9.5%0.7% | 336−74.8%0.5% | 235−43.0%0.4% | 410+18.8%0.7% | 619−42.3%1.0% | 1,333+47.9%2.2% | 412—0.8% | 345—0.7% | 1,072—2.1% | 901—1.8% | |
| Current assets | 53,946—70.4% | 53,946+6.4%70.4% | 53,248+12.6%71.5% | 53,710+7.5%71.6% | 49,186+11.0%79.0% | 50,723+31.7%78.9% | 47,295+29.2%77.3% | 49,943+38.9%77.7% | 44,300+21.0%73.4% | 38,502—70.9% | 36,611—69.8% | 35,957—71.1% | 36,600—71.2% | |
| Property, plant and equipment | 5,359—7.0% | 5,359—7.0% | 5,373+4.3%7.2% | — | — | — | 5,153+2.6%8.4% | 6,085+17.2%9.5% | 6,108+14.6%10.1% | 5,183—9.5% | 5,024r5,024—9.6% | 5,191—10.3% | 5,331—10.4% | |
| Right-of-use (leased) assets | 2,048—2.7% | 2,048+118%2.7% | 602−42.7%0.8% | 716−38.2%1.0% | 830−34.4%1.3% | 941−31.3%1.5% | 1,050−28.7%1.7% | 1,158−26.5%1.8% | 1,265−24.5%2.1% | 1,370—2.5% | 1,473—2.8% | 1,575—3.1% | 1,675—3.3% | |
| Goodwill | 6,525—8.5% | 6,525—8.5% | 6,525—8.8% | 6,525—8.7% | — | — | — | — | — | — | — | — | — | |
| Other intangible assets | 666—0.9% | 666+3405%0.9% | 686+2538%0.9% | 712+2058%0.9% | 12−70.0%0.0% | 19−59.6%0.0% | 26−51.9%0.0% | 33−45.9%0.1% | 40−41.2%0.1% | 47—0.1% | 54—0.1% | 61—0.1% | 68—0.1% | |
| Long-term investments | 497—0.6% | 497+234%0.6% | 504+241%0.7% | — | 135−91.7%0.2% | 149−89.9%0.2% | 148−90.5%0.2% | 111−92.8%0.2% | 1,619+7.3%2.7% | 1,475—2.7% | 1,563—3.0% | 1,543—3.1% | 1,509—2.9% | |
| Total assets | 76,589—100% | 76,589+19.1%100% | 74,509+21.8%100% | 74,977+16.7%100% | 62,256+3.1%100% | 64,298+18.4%100% | 61,192+16.6%100% | 64,273+27.2%100% | 60,374+17.4%100% | 54,308—100% | 52,477—100% | 50,548—100% | 51,427—100% | |
| Accounts payable | 5,321—6.9% | 5,321+34.2%6.9% | 4,262−7.6%5.7% | 5,246−12.0%7.0% | 4,111−27.7%6.6% | 3,965−10.7%6.2% | 4,614+2.2%7.5% | 5,962+73.6%9.3% | 5,689+95.6%9.4% | 4,442—8.2% | 4,513—8.6% | 3,435—6.8% | 2,909—5.7% | |
| Current liabilities | 12,884—16.8% | 12,884−5.3%16.8% | 12,983−11.3%17.4% | 14,636−20.1%19.5% | 12,201−28.8%19.6% | 13,602+20.5%21.2% | 14,629+13.5%23.9% | 18,317+75.8%28.5% | 17,139+71.6%28.4% | 11,285—20.8% | 12,892—24.6% | 10,419—20.6% | 9,990—19.4% | |
| Lease liabilities (non-current) | 2,089—2.7% | 2,089+276%2.7% | 627−8.5%0.8% | 838+3.1%1.1% | 419−55.4%0.7% | 555−47.8%0.9% | 685−42.0%1.1% | 813−37.4%1.3% | 939−33.6%1.6% | 1,063—2.0% | 1,182—2.3% | 1,299—2.6% | 1,415—2.8% | |
| Non-current liabilities | 14,359—18.7% | 14,359+56.4%18.7% | 13,893+39.9%18.6% | 15,143+41.9%20.2% | 8,424−26.2%13.5% | 9,183−24.4%14.3% | 9,931+13.9%16.2% | 10,674+16.1%16.6% | 11,413+18.3%18.9% | 12,146—22.4% | 8,718—16.6% | 9,191—18.2% | 9,651—18.8% | |
| Total liabilities | 27,243—35.6% | 27,243+19.6%35.6% | 26,876+9.4%36.1% | 29,779+2.7%39.7% | 20,625−27.8%33.1% | 22,785−2.8%35.4% | 24,560+13.7%40.1% | 28,991+47.8%45.1% | 28,552+45.4%47.3% | 23,431—43.1% | 21,610—41.2% | 19,610—38.8% | 19,641—38.2% | |
| Retained earnings | 49,346—64.4% | 49,346+21.5%64.4% | 47,633+32.6%63.9% | 45,198+30.1%60.3% | 41,631+32.3%66.9% | 40,608+38.0%63.2% | 35,928+33.3%58.7% | 34,731+36.9%54.0% | 31,456+27.3%52.1% | 29,416—54.2% | 26,950—51.4% | 25,363—50.2% | 24,708—48.0% | |
| Shareholders' equity | 49,346—64.4% | 49,346+18.9%64.4% | 47,633+30.0%63.9% | 45,198+28.1%60.3% | 41,613r41,631+30.8%66.8% | 41,513+34.4%64.6% | 36,632+18.7%59.9% | 35,282+14.0%54.9% | 31,822+0.1%52.7% | 30,877—56.9% | 30,867—58.8% | 30,938—61.2% | 31,786r31,786—61.8% | |
| Total liabilities and equity | 76,589—100% | 76,589+19.1%100% | 74,509+21.8%100% | 74,977+16.7%100% | 62,256+3.1%100% | 64,298+18.4%100% | 61,192+16.6%100% | 64,273+27.2%100% | 60,374+17.4%100% | 54,308—100% | 52,477—100% | 50,548—100% | 51,427—100% | |
| Shares outstanding | 3.2—— | 3.2−1.8%— | 3.2−2.3%— | 3.2−2.0%— | 3.2−1.6%— | 3.3−1.1%— | 3.3−3.0%— | 3.3−5.5%— | 3.3−7.9%— | 3.3—— | 3.4—— | 3.5—— | 3.5—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 1,486+19.1%1.9% | 403+29.6%2.0% | 406*+29.3%2.0% | 363*+17.1%1.8% | 314*+0.3%1.7% | 311+3.0%1.7% | 314*+2.6%1.8% | 310*+8.4%1.8% | 313*+9.8%1.9% | 302—2.0% | 306*—2.0% | 286*—2.0% | 285r286*—2.3% | |
| Share-based compensation | 662+9.8%0.8% | 135−16.1%0.7% | 177*+14.9%0.9% | 186*+17.7%0.9% | 164*+26.2%0.9% | 161+42.5%0.9% | 154*+806%0.9% | 158*−21.8%0.9% | 130*−34.3%0.8% | 113—0.8% | 17*—0.1% | 202*—1.4% | 198r197*—1.6% | |
| Cash from operating activities | 11,422—14.4% | 6,490+181%31.6% | −273*—−1.3% | 1,633*+117%8.2% | 3,572*—19.1% | 2,310+22.4%12.5% | −173*−117%−1.0% | 754*−81.5%4.3% | −4,150*−685%−24.7% | 1,887—12.7% | 1,045r1,020*—7.0% | 4,077*—28.5% | 710*—5.6% | |
| Capital expenditure | −731—−0.9% | −346—−1.7% | −203*—−1.0% | −112*—−0.6% | −70*—−0.4% | −98—−0.5% | −93*—−0.5% | −180*—−1.0% | −542*—−3.2% | −431—−2.9% | — | −117*—−0.8% | −633*—−5.0% | |
| Cash from investing activities | 3,665+3758%4.6% | −346—−1.7% | 198*—1.0% | −5,055*−393%−25.3% | 8,868*—47.5% | −98—−0.5% | −992*—−5.7% | 1,727*—9.9% | −542*—−3.2% | −431—−2.9% | −107*—−0.7% | −117*—−0.8% | −1,883*—−15.0% | |
| Debt issued | — | — | — | — | — | — | — | 4,400*—25.3% | 3,500*—20.8% | 4,990—33.5% | — | 0*—0.0% | — | |
| Shares bought back | — | −600—−2.9% | −600*—−2.9% | −601*—−3.0% | — | — | 0*—0.0% | 0*—0.0% | −1,193*—−7.1% | −2,311—−15.5% | −1,675*—−11.1% | −1,723*—−12.1% | — | |
| Cash from financing activities | −3,842—−4.8% | −2,577—−12.5% | −1,726*—−8.5% | 5,462*+184%27.4% | −5,001*−398%−26.8% | −2,117—−11.4% | −2,889*—−16.5% | 1,926*—11.1% | 1,677*+201%10.0% | −1,006—−6.8% | −1,526r−1,501*—−10.2% | −2,030*—−14.2% | 558*—4.4% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Executive pay at Pro-Dex, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2026Rick | $728 K | $1.1 M | $354 K | $307 |
| 2025Rick | $653 K | $1.9 M | $358 K | $226 |
| 2024Rick | $441 K | $397 K | $321 K | $103 |
Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026
Events at Pro-Dex, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Auditor changedFiling
Auditor changed 1 · Acquisition or sale completed 1 · Directors and officers 8 · Material agreement 6 · New debt 4 · Shareholder vote 2 · Results announced 10
| Filed | What happened | Filing |
|---|---|---|
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Acquisition or sale completedMaterial agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Auditor changed | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Material agreementNew debt | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Oct 30, 2026
H-1B hiring at Pro-Dex, Inc.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $115 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| VALIDATION SUPERVISORValidation Engineers | 1 | $115 K |
Where: Tustin, CA 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $115 K | 1 |
| FY2023 | 1 | 1 | $105 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Pro-Dex, Inc.
Product recalls by Pro-Dex, Inc.#
5 recalls since 2015, 6,262 units in the notices that give a number. Medical devices (FDA): 5.
| Date | What and why | Units | Notice |
|---|---|---|---|
| KLS Martin Battery Pack, REF: KLS BP2 001, and KLS BP2 040 (bulk case of 40), used in conjunction with the KLS Martin MaxDriver 2.0 surgical driver, REF: KLS-SD-2000The packaging of a sterile battery, intended to power a surgical screwdriver, may contain Tyvek shavings inside the sterile package.Medical devicesClass II | 2,000 | Z-0280-2025 | |
| KLS Martin Battery Pack, REF: KLS BP 001, and KLS BP 040 (bulk case of 40), used in conjunction with the KLS Martin MaxDriverBattery packs used in surgical procedures where a surgeon uses a powered screwdriver and a right-angle attachment have switched manufacturing and expiration dates on sterile pouch labels, so batteries will appear to be prematurely expired.Medical devicesClass II | 2,000 | Z-2098-2023 | |
| KLS martin Group KLS E-COUPLING ADAPTER REF PDEC-1000-2 E-Coupling Adapter Assembly used to connect the KLS driver (e.g. drill) to a driver bit that fits into the adapter.Incorrect Unique Device Identifier/GTIN code was used on product.Medical devicesClass II | 199 | Z-1391-2023 | |
| PRO-DEX Surgical Driver Battery Pack PDBP-001 Series PRO-DEX Battery Pack, Single Pouch - PDBP-001-2 PRO-DEX Battery Pack, 40 Pouches - PDBP-040-2 Product Usage: -The PDBP-001 Battery is a single use (non-rechargeable) sterile lithium ion battery accessory that powers the PDSD Surgical driver. There is only one PDSD Surgical dr…Visual particulates within a battery Tyvek pouch. The battery is provided sterile for use with surgical drivers.Medical devicesClass II | 68 | Z-2340-2019 | |
| Battery Pack KLS-SD-1000 Single Models: KLS-BP-001 Used to power the KLS Martin Max Driver (battery powdered surgical screwdriver). (and 1 more products)The sterile battery may contain particulates within the sterile package.Medical devicesClass II | 1,995 | Z-1095-2016 |
Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| Not stated | Restructuring planSEC 8-K | Company-wide plan | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Pro-Dex, Inc. compares in Medical Instruments
- Market cap$199 M · higher than 24% of 116
- Revenue$78 M · higher than 16% of 120
- Net margin15.1% · higher than 73% of 114
- Revenue growth16.5% · higher than 77% of 49
- P/E ratio16.6× · lower than 82% of 68
- Price / sales2.5× · lower than 60% of 85
- Price / book4.2× · lower than 40% of 84
- FCF yield3.4% · higher than 68% of 39
Peer comparison · Medical Instruments
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Pro-Dex, Inc.🇺🇸 | $199 M | 16.6× | 15.1% | +16.5% |
| Intuitive Surgical, Inc.🇺🇸 | $155.6 B | 52.6× | 25.5% | +20.5% |
| EssilorLuxottica S.A.🇫🇷 | $88.0 B | 32.1× | 8.1% | +4.5% |
| HOYA Corporation🇯🇵 | $56.2 B | 32.8× | 25.4% | — |
| Becton, Dickinson and Company🇺🇸 | $54.0 B | 57.4× | 4.2% | +8.2% |
| Alcon Inc.🇨🇭 | $37.1 B | 37.9× | 9.4% | +4.9% |
| ResMed Inc.🇺🇸 | $35.3 B | 22.1× | 27.8% | +9.8% |
| West Pharmaceutical Services, Inc.🇺🇸 | $27.1 B | 42.4× | 18.8% | +6.3% |
| Terumo Corporation🇯🇵 | $24.9 B | 27.0× | 12.0% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 28, 2026
- Annual results:
- For year ending June-2026
- Balance sheet:
- As of June-2026
- Employees:
- As of June 30, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Pro-Dex, Inc.? Verify and update this profile — free
Show Pro-Dex, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.